Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
HCA Healthc J Med ; 3(5): 271-282, 2022.
Article in English | MEDLINE | ID: mdl-37425250

ABSTRACT

Objective: There has been an increase in ophthalmology fellowship training programs and applicants. The current ophthalmology literature lacks any recent study examining factors influencing residents' decisions to pursue subspecialty fellowship training. Methods: An anonymous, 16-item survey was distributed to residents from a convenience sample of ophthalmology residency programs by their program directors or administrators. Results: A total of 72 residents and 9 interns from 9 distinct programs completed the survey. Eighty-two percent of respondents reported they have either applied or will apply for a fellowship position. Gender and race showed no significant association with fellowship application. Respondents perceived that obtaining a fellowship position would be easier (61%) than obtaining an ophthalmology residency. The desire for additional clinical and surgical training were the 2 primary factors for the pursuit of fellowship training. Half of those pursuing fellowship training (49%) indicated they still desired to practice comprehensive ophthalmology. None of the respondents indicated they wished to practice in a rural area. Conclusion: The data collected in this pilot study elicited factors and variable associations that provide a sound basis for informing revisions and improvements to the data collection tool for a follow-up prospective, longitudinal study involving all ACGME ophthalmology training programs. The results indicate some of the essential factors associated with the pursuit of fellowship training by the current generation of residents. The results also highlight potential trends related to residents' views of their training and desired practice patterns.

2.
J Acad Ophthalmol (2017) ; 10(1): e150-e157, 2018 Jan.
Article in English | MEDLINE | ID: mdl-30662977

ABSTRACT

OBJECTIVE: To develop a probability model of matching into a US ophthalmology residency program using San Francisco Matching Program (SF Match) data. DESIGN: Retrospective data analysis of de-identified application and matching data. PARTICIPANTS: Registrants for the 2013, 2014, and 2015 ophthalmology residency matches conducted by the SF Match. METHODS: Descriptive statistics of candidates, comparison of continuous and categorical variables between matched and nonmatched candidates, and linear regression modeling were performed. A recursive partitioning method was used to create a probability of matching algorithm. MAIN OUTCOME MEASURES: Probability of successfully matching based on quantifiable candidate characteristics. RESULTS: Over the 3-year period, 1,959 individuals submitted an average of 64 applications and received a mean of nine interview invitations. The overall match rate was 71%, with 78% matching at one of their top five choices. Successful matches were more likely to occur in US medical school graduates (78% vs 20%, p < 0.001) and applicants on their first attempt (76% vs 29%, p < 0.001). The association between matching and number of programs applied became negative with > 48 applications. Probability of matching was "high" (> 80%) among US graduates with a step 1 United States Medical Licensing Examination (USMLE)score>243(regardless of number of programs applied to), a step 1 USMLE score of 231 to 243 who applied to at least 30 programs, and first-time applicants with a step 1 score >232. No international medical graduates or repeat applicants had a "high" probability of matching. CONCLUSIONS: Although advice must be individualized for each candidate, applicants for ophthalmology residency who fall into a "high" probability of matching group are likely to be successful with applications to 45 or fewer programs. Applying to 80 or more programs should be considered for international medical graduates and/or applicants who are previously unmatched. Modification of the match application data form may allow more detailed analysis of variables such as Alpha Omega Alpha or Gold Humanism Honor Society membership, research activity, and composite evaluation on a standardized letter of recommendation.

3.
BMC Ophthalmol ; 17(1): 85, 2017 Jun 07.
Article in English | MEDLINE | ID: mdl-28592279

ABSTRACT

BACKGROUND: A growing proportion of veterans treated at the Veterans Health Administration (VA) have a history of post-traumatic-stress-disorder (PTSD), and there exists a higher rate of PTSD amongst veterans than the general population. The purpose of this study is to determine the correlation between PTSD and intra-operative analgesia, intra-operative time, and anesthesia type for cataract surgery in a veteran population. Secondary objectives are to determine if patient age, and first or second eye surgery affect intra-operative pain control or are correlated with type of anesthesia modality. METHODS: A retrospective study of 330 cataract surgeries performed by resident physicians between January and September 2012 at the Veterans Affairs Medical Center Tennessee Valley Healthcare System, Nashville and Murfreesboro Campuses was completed. Three hundred and thirty veteran patients were selected if their cataract surgery was performed between January and September 2012. Combined cases were excluded. The primary outcome evaluated was intra-operative analgesia. Secondary outcomes included history of post-traumatic-stress-disorder, anesthesia type, first or second eye, pain control, intra-operative heart rate and blood pressure, age, and case complexity. Data was analyzed using an unpaired two-sample Welch's t-test assuming unequal variance and Z test of comparison of proportions. RESULTS: Patients with post-traumatic-stress-disorder reported higher pain scores, had longer operative times, and were more likely to have received a retrobulbar block. Operative time was not associated with an increased pain score, irrespective of anesthesia type, when controlled for PTSD. Complex cases had longer operative times, more sedation, and higher pain scores. P < 0.05 was used consistently. CONCLUSIONS: Post-traumatic stress disorder and anxiety are more prevalent in the veteran population. Our data suggests that a history of post-traumatic-stress-disorder was correlated with higher pain scores, longer operative times, and with having received a retrobulbar block. Patients without a history of PTSD were more likely to have received topical anesthesia with or without sedation. The veteran population requires more sedation to allay anxiety and perceptions of discomfort, which may account for longer surgical times. The veteran population is a special population and it is important to investigate how PTSD in the veteran population affects intra-operative analgesia.


Subject(s)
Anesthesia, Local/methods , Cataract Extraction/methods , Cataract/complications , Pain, Postoperative/prevention & control , Stress Disorders, Post-Traumatic/complications , Veterans , Aged , Aged, 80 and over , Anesthetics, Local/administration & dosage , Humans , Intraoperative Period , Male , Middle Aged , Pain Measurement , Patient Satisfaction , Retrospective Studies , Treatment Outcome
4.
Retina ; 31(7): 1316-22, 2011.
Article in English | MEDLINE | ID: mdl-21358364

ABSTRACT

PURPOSE: To determine the long-term potency, sterility, and stability of vancomycin, ceftazidime, and moxifloxacin prepared in single-use polypropylene syringes for intravitreal injection. METHODS: Experimental study. Vancomycin 1 mg/0.1 mL, ceftazidime 2 mg/0.1 mL, and moxifloxacin 160 µg/0.1 mL were compounded and prepared in 1-mL polypropylene syringes and stored at 4 °C, -20 °C, and -80 °C. Antibiotic potency, sterility, pH, osmolality, and concentration were tested at baseline and at 1, 2, 4, 8, 12, and 24 weeks after preparation. RESULTS: Potency, sterility, and stability were preserved for all 3 antibiotics at all temperatures out to 24 weeks, although there was a trend toward reduced potency at Week 24 for vancomycin and ceftazidime stored at 4°C. The largest zones of inhibition for Staphylococcus epidermidis and S. aureus were consistently demonstrated by moxifloxacin. CONCLUSION: Vancomycin, ceftazidime, and moxifloxacin prepared in single-use polypropylene syringes retain potency, sterility, and stability out to 24 weeks when stored at -20 °C or -80 °C. The results of this study may have important implications for the current management of endophthalmitis.


Subject(s)
Anti-Bacterial Agents/pharmacology , Aza Compounds/pharmacology , Bacteria/drug effects , Ceftazidime/pharmacology , Endophthalmitis/drug therapy , Eye Infections, Bacterial/drug therapy , Quinolines/pharmacology , Vancomycin/pharmacology , Anti-Bacterial Agents/chemistry , Aza Compounds/chemistry , Ceftazidime/chemistry , Cryopreservation , Disk Diffusion Antimicrobial Tests , Drug Compounding , Drug Resistance, Bacterial , Drug Stability , Drug Storage , Drug-Related Side Effects and Adverse Reactions , Endophthalmitis/microbiology , Eye Infections, Bacterial/microbiology , Fluoroquinolones , Hydrogen-Ion Concentration , Intravitreal Injections , Moxifloxacin , Ophthalmic Solutions , Osmolar Concentration , Quinolines/chemistry , Syringes , Vancomycin/chemistry
5.
Am J Ophthalmol ; 139(3): 557-9, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15767078

ABSTRACT

PURPOSE: To describe the ocular involvement in xanthoma disseminatum. DESIGN: Case report and literature review. METHODS: Histopathologic study of excised conjunctival tumor and clinical follow-up. RESULTS: A 29-year-old woman with normal serum lipoproteins developed widespread xanthomas of the skin, throat, and episclera. There were no signs of recurrence 12 months after removal of the conjunctival xanthomas. CONCLUSIONS: Xanthoma disseminatum is a rare condition for which there is no medical treatment. The distinction between the normolipemic xanthomatoses awaits a better understanding of their pathogenesis. Surgical removal of episcleral xanthomas can be successful, but long-term follow-up of such patients has been limited.


Subject(s)
Conjunctival Diseases/complications , Histiocytosis, Non-Langerhans-Cell/complications , Scleral Diseases/complications , Skin Diseases/complications , Adult , Conjunctival Diseases/pathology , Conjunctival Diseases/surgery , Female , Histiocytosis, Non-Langerhans-Cell/pathology , Histiocytosis, Non-Langerhans-Cell/surgery , Humans , Scleral Diseases/pathology , Scleral Diseases/surgery , Skin Diseases/pathology , Skin Diseases/surgery
6.
Invest Ophthalmol Vis Sci ; 44(11): 4853-8, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14578408

ABSTRACT

PURPOSE: Ibopamine is a prodrug of epinine (deoxyepinephrine) that exhibits activity at dopaminergic and adrenergic receptors. Topical ocular application has been shown to cause mydriasis without cycloplegia and to increase the rate of aqueous humor flow in normotensive human eyes. Mydriasis can interfere with the measurement of aqueous flow. In this study ibopamine's effect on aqueous humor production was measured while making allowance for the potential artifact caused by its mydriatic effect. METHODS: The effects of topical ibopamine on pupillary diameter, aqueous humor flow measured by fluorophotometry, and intraocular pressure were studied in 24 healthy, blue-eyed humans. Ibopamine was administered with and without the alpha-adrenergic antagonist dapiprazole, and its effects were compared with those of tropicamide, with and without dapiprazole in a double-masked, randomized, crossover design. RESULTS: Ibopamine dilated the pupil from a diameter of 3.7 +/- 0.64 (mean +/- SD, n=24) to 7.7 +/- 0.70 mm. Ibopamine, during its peak mydriasis, was associated with a very large increase in the rate of clearance of topically applied fluorescein from the cornea and anterior chamber, an effect that was not associated with tropicamide during its peak mydriasis. The mydriatic effect of ibopamine was completely blocked by dapiprazole, and the increase in fluorescein clearance was partially blocked. When mydriasis was blocked, ibopamine increased fluorescein clearance by 13% (P<0.0001), which was interpreted as an increased rate of aqueous humor production. Compared with placebo and with the tropicamide control, ibopamine decreased intraocular pressure, despite its stimulation of aqueous humor flow. CONCLUSIONS: Ibopamine is in a specific class of drug, along with pilocarpine, epinephrine, and bimatoprost that in humans increases the rate of aqueous humor flow as measured by fluorophotometry. This effect is partly responsible for its ability to increase intraocular pressure in persons suspected to have abnormally low aqueous humor outflow facility. The transient apparent doubling of aqueous humor flow, measured by fluorescein clearance after administration of ibopamine is an artifact of increased fluorescein clearance through the dilated pupil while accommodation is active.


Subject(s)
Aqueous Humor/metabolism , Deoxyepinephrine/analogs & derivatives , Deoxyepinephrine/pharmacology , Intraocular Pressure/drug effects , Mydriatics/pharmacology , Pupil/drug effects , Adrenergic alpha-Antagonists/administration & dosage , Adrenergic alpha-Antagonists/pharmacology , Adult , Cross-Over Studies , Deoxyepinephrine/administration & dosage , Double-Blind Method , Drug Combinations , Fluorescein/metabolism , Fluorophotometry , Humans , Mydriatics/administration & dosage , Ophthalmic Solutions , Piperazines , Prodrugs , Triazoles/administration & dosage , Triazoles/pharmacology , Tropicamide/administration & dosage , Tropicamide/pharmacology
7.
Am J Ophthalmol ; 133(3): 333-6, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11860969

ABSTRACT

PURPOSE: To determine the amount of pupillary constriction to four different concentrations of pilocarpine in normal human subjects and to determine if pupillary constriction correlates with bioavailability of the instilled concentrations. The amount of pupillary constriction to dilute pilocarpine is utilized as a diagnostic test for Adie tonic pupil as distinguished from a normal pupil response. DESIGN: Twenty healthy volunteers had automated binocular infrared pupillography in the dark after instillation of four different concentrations of dilute pilocarpine. Ocular penetration of eye drops was also assessed using 2% fluorescein sodium as a tracer. METHODS: Prospective institutional double-masked study of both eyes of twenty healthy volunteers, ten with brown irides, ten with blue irides, between the ages of 20-40 years. RESULTS: A pilocarpine dose-dependent curve showed decreased pupil size within 15 minutes, peaking at 30-60 minutes. No difference was noted between right and left eyes, iris color, or corneal permeability. CONCLUSIONS: Normal pupils constrict to dilute concentrations of pilocarpine (0.25% or 0.125%), but constrict insignificantly to concentrations of 0.0313% or 0.0625%. Pupil constriction with 0.0625% pilocarpine should distinguish an Adie pupil from normal. This confirms the utility of this simple office diagnostic procedure.


Subject(s)
Miotics/administration & dosage , Pilocarpine/administration & dosage , Pupil/drug effects , Tonic Pupil/diagnosis , Adult , Biological Availability , Cornea/metabolism , Double-Blind Method , Eye Color , Female , Fluorophotometry , Humans , Male , Miotics/pharmacokinetics , Ophthalmic Solutions/administration & dosage , Ophthalmic Solutions/pharmacokinetics , Pilocarpine/pharmacokinetics , Prospective Studies , Tears/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...